Berger Montague PC is investigating Hims & Hers Health, Inc. for potential breaches of fiduciary duties, focusing on allegations that the company improperly shared private user health data with advertisers, engaged in deceptive billing practices, and made subscription cancellations difficult. This probe could impact the company's reputation and shareholder trust. Shareholders are encouraged to contact the law firm for more information as the investigation unfolds.
Hims & Hers Health is under federal investigation and lawsuit for alleged deceptive billing, difficult subscription cancellations, and unauthorized sharing of health data with advertisers. Barclays lowered its price target from $39 to $35, reflecting...
Hims & Hers Health has experienced a significant surge in international revenue, growing over 17-fold year-over-year to $131 million, driven by its acquisition of Eucalyptus and expansion into new markets. The company aims to exceed $600 million in i...
Berger Montague PC has initiated an investigation into Hims & Hers Health, Inc.'s Board of Directors over potential breaches of fiduciary duties. The probe focuses on allegations that the company improperly shared private user health data with advert...
